Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M6,024Revenue $M863Net Margin (%)56.1Altman Z-Score14.6
Enterprise Value $M5,550EPS $11.9Operating Margin %61.1Piotroski F-Score7
P/E(ttm)12.3Beneish M-Score-2.0Pre-tax Margin (%)67.4Higher ROA y-yY
Price/Book4.210-y EBITDA Growth Rate %--Quick Ratio4.5Cash flow > EarningsN
Price/Sales6.95-y EBITDA Growth Rate %51.6Current Ratio4.9Lower Leverage y-yY
Price/Free Cash Flow15.5y-y EBITDA Growth Rate %32.4ROA % (ttm)32.7Higher Current Ratio y-yY
Dividend Yield %--PEG0.2ROE % (ttm)40.2Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M42.8ROIC % (ttm)66.7Gross Margin Increase y-yY

Gurus Latest Trades with NYSE:TARO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
TAROHOTCHKIS & WILEY 2015-03-31 Reduce$141.03 - $171.77
$ 140.60-9%Reduce 2.05%207,158
TAROHOTCHKIS & WILEY 2014-12-31 Reduce-0.03%$134.21 - $164.24
$ 140.60-4%Reduce 23.11%211,499
TAROHOTCHKIS & WILEY 2014-09-30 Reduce-0.12%$137.98 - $162.12
$ 140.60-7%Reduce 46.17%275,064
TAROHOTCHKIS & WILEY 2013-12-31 Add0.04%$75.22 - $99.05
$ 140.6062%Add 20.80%529,936
TAROHOTCHKIS & WILEY 2013-09-30 Buy 0.15%$56.9 - $73.8
$ 140.60117%New holding438,675
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NYSE:TARO is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!

NYSE:TARO: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about NYSE:TARO:

    News about NYSE:TARO:

    Articles On GuruFocus.com
    These Companies Show High Profit and Low Debt Jun 17 2015 
    Ontario to See $3.66 Billion in Project Construction Starts in Second-Quarter 2015, Fueled by Natura Mar 18 2015 
    Pharmaceutical Industry on the Cusp Of Change Jun 02 2014 
    Teva Pharmaceutical (TEVA) Dividend Stock Analysis Jun 28 2013 
    taro pharma could double Aug 26 2012 
    What do people think of TARO Aug 26 2012 
    TARO Shares are Mispriced Compared to Competitors Like Perrigo and Teva May 10 2012 
    Sun Pharmaceutical Extends Tender Offer for Taro Dec 19 2008 

    More From Other Websites
    No related articles found.

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

    GuruFocus Premium Plus Membership